- This is a translational review combining clinical evidence and preclinical mechanistic models on postsurgical pain prediction and prevention.
- It covers perioperative bio-psycho-social risk factors for acute-to-chronic postsurgical pain, plus emerging biological signatures for risk stratification.
- The authors argue that current risk assessment tools lack sufficient precision, reliability, and generalizability, and that risk evolves across pre-, intra-, and postsurgical phases.
- They propose integrating bio-psycho-social factors into clinically relevant prognostic models to support mechanism-based, personalized prevention in vulnerable patients.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This narrative review synthesizes animal and human studies on the brain sites involved in endogenous pain modulation.
- It focuses on the best-characterised pathway, running from the midbrain periaqueductal gray to the rostral ventromedial medulla and then to the dorsal horn or spinal trigeminal nucleus.
- These circuits are conserved and can modulate pain largely independently of cortex, though the prefrontal cortex can influence them, and their organisation may change in persistent pain.
- Ultra-high-field fMRI now allows imaging of brainstem nuclei at millimetre-cubed scale, which standard MRI's limited resolution had previously prevented.
- This paper summarises the ENTRUST-PE framework, developed by an international, interdisciplinary network to enhance trustworthiness in pain research.
- The framework proposes seven core values, including methodological rigour, openness and transparency, and patient and public involvement, with recommendations for different interest holders.
- The authors reflect on the community's response since the 2024 launch and consider challenges and opportunities in the evolving research landscape.
- They suggest how the field might move toward deeper implementation of the framework.
- This narrative review synthesizes mechanistic work on chloride dysregulation in chronic pain, and the abstract reports no sample size or clinical data.
- It focuses on injury-induced downregulation of the potassium-chloride cotransporter KCC2 in spinal dorsal horn neurons as a substrate for loss of spinal inhibition.
- The authors argue that chloride dysregulation could explain neuropathic pain features such as hyperalgesia, allodynia, and spontaneous pain, and could account for benzodiazepine analgesic failure.
- They conclude that KCC2 is a promising novel target for both analgesia and disease modification in chronic pain.
- Randomized equivalence trial of 84 adults with chronic non-specific low back pain and probable nociplastic features, conducted at a single rehabilitation department.
- Participants received weekly IV lidocaine (1 mg/kg bolus, then 4 mg/kg infusion over 4 weeks) or saline placebo, with all receiving amitriptyline and aerobic exercise.
- At 3 months, the VAS difference was 0.24 (90% CI -0.33 to 0.81), within the prespecified ±1.5 equivalence bounds (TOST P < .001); sleep quality favored lidocaine (mean difference 1.81; 95% CI 0.49-3.14; P = .027).
- The authors concluded lidocaine gave no additional analgesia over saline alongside multimodal care, and adverse events were more frequent with lidocaine but mild and transient.
AI summary not available. Read the source abstract on PubMed.
- This statewide registry analysis of 34,505 surgical patients from 2017 to 2019 used machine learning to rank predictors of opioid prescribing and consumption.
- No intervention was tested; the models assessed prescription receipt, likelihood of consumption, and amount consumed, ranked by variable importance scores.
- Of patients, 31% received no prescription, 18% were prescribed but reported no use, and 52% were prescribed and reported some consumption.
- The authors identify overlapping predictors (age, procedure type, BMI, prescription quantity, smoking) and suggest targeting modifiable factors such as prescription quantity in stewardship efforts.
AI summary not available. Read the source abstract on PubMed.
- Phase 2b randomized, double-blind, placebo-controlled dose-ranging trial in 110 participants after third molar extraction.
- Oral meloxicam formulation MR-107A-02 given at 1.25, 5, or 15 mg twice daily was compared with placebo.
- Mean SPID0-24 Emax values were 70.7, 86.7, and 94.8 across the doses, versus 52.0 for placebo; 5 and 15 mg were significant (p < .001).
- The 15 mg dose gave perceptible relief at 0.6 hours and meaningful relief at 1.5 hours, with the lowest rescue use (29.6%); authors report good tolerability.
- Secondary analysis of baseline data from 685 participants pooled from two clinical trials, with 44% living in rural areas and 96% female.
- Rurality and sociodemographic characteristics were examined as baseline factors associated with fibromyalgia severity and other symptom measures.
- FIQR was associated with age, race, marital status, education, employment, and income but not rurality (t = -0.350, P = 0.726), and sociodemographics explained R2 = 0.09 of FIQR variance.
- The authors conclude that sociodemographic factors and rurality had limited influence on fibromyalgia severity, pain, fatigue, and pain catastrophizing.
- This cross-sectional study of 138 female adolescents with varying menstrual pain examined whether catastrophizing and fatigue mediate links between sensory sensitivity and pain interference.
- Multisensory sensitivity was measured with the Sensory Hypersensitivity Scale, and mediation analyses controlled for pain severity ratings.
- Multisensory sensitivity was linked to non-menstrual pain interference through catastrophizing and fatigue (combined indirect effect 1.80, 95% CI 0.81-3.10), but had no direct effect on menstrual pain interference.
- The authors suggest these factors show early functional impact and may offer an opportunity for earlier identification and intervention in this group.
- Randomized within-patient trial of 48 adults (96 leads) receiving bilateral thoracic percutaneous spinal cord stimulator trial leads at one academic center.
- One lead in each patient was randomly anchored with Dermabond and the contralateral lead with suture, and upright radiographic migration was compared.
- Mean absolute migration was 9.15 mm with Dermabond versus 10.60 mm with suture (paired difference -1.46 mm, 95% CI -6.73 to 3.81; P = .58).
- Male sex and prior spine surgery predicted more migration, while fixation method did not; the authors call Dermabond clinically comparable to suture.
- Prospective observational study of 60 ASA I-II women undergoing elective total abdominal hysterectomy under general anesthesia, analyzed after six exclusions.
- Compared general anesthesia alone (n = 29) with general anesthesia plus adjunctive truncal regional block (n = 31).
- Richards-Campbell Sleep Questionnaire scores were higher with the block (73.0 ± 11.1 vs 47.9 ± 16.9; P < .001), and modified PSQI worsened only in the anesthesia-alone group (9.0 ± 2.4 to 11.7 ± 2.2; P < .001).
- Authors report lower pain scores and higher satisfaction with the block, and 12-hour VAS pain was the strongest predictor of postoperative PSQI (β = 0.56, P < .001).
- This technical note describes an anatomy-based approach to deciding which cervical medial branch nerves remain targetable after cervical fusion.
- The method draws on surgical approach, anatomic landmarks, implant trajectory, and cross-sectional imaging, and the abstract reports no patient numbers or outcome data.
- The authors state that posterior screw-and-rod fusion essentially always denervates the medial branch at operated levels, while anterior approaches reliably preserve these nerves.
- They conclude that a systematic, anatomy-based method improves diagnostic precision and reduces unnecessary procedures, but the abstract offers no data to test that claim.
- Systematic review and meta-analysis of 67 identified studies, with 56 included quantitatively, on work outcomes after implanted neurostimulation for chronic pain.
- Work status was compared before and after neurostimulator implantation using paired odds, pooled across studies.
- Paired odds of working rose after implantation (OR 5.17, 95% CI 2.89-9.23, P < .0001), and the pooled proportion returning to work was 26.05% (95% CI 20.73%-32.18%).
- The authors conclude that implanted electrical neurostimulation is associated with increased odds of work, with the best effects after peripheral nerve stimulation and in head-related pain.
- An expert panel convened by the American Academy of Pain Medicine Foundation reviewed English-language studies from 2015 to 2025 and used a Delphi process to reach consensus.
- The guideline covers many neuromodulation options, including brain-computer interfaces, vagus nerve stimulation, spinal cord stimulation for motor restoration, and transcranial magnetic stimulation.
- The abstract reports no effect sizes; it says evidence is still evolving, with promising signals for post-stroke upper limb function, functional spine outcomes, and chronic pain.
- The authors conclude these technologies are promising for neuromuscular restoration and call for larger, higher-quality studies with consistent outcome measures.
- Cross-sectional baseline analysis of 212 parents with abdominal pain-related brain-gut disorders and their 4-7-year-old children, drawn from a preventative randomized trial.
- Latent mixture modeling identified three family subgroups defined by combinations of socioeconomic status, pain burden, distress, and family resilience.
- The subgroups comprised 55%, 13%, and 32% of families, and two higher-risk groups had lower child emotional functioning than the high-functioning group.
- The authors conclude that these family risk and resilience patterns may help identify children vulnerable to chronic abdominal pain and target preventive interventions.
- This case series describes three patients with pathological vertebral compression fractures from spinal tumors who received concurrent basivertebral nerve radiofrequency ablation and vertebral augmentation.
- The intervention was combined BVN radiofrequency ablation plus vertebral augmentation; no comparator group was used.
- All three patients reported immediate and sustained pain reduction with improved function, and no peri- or post-procedural complications were seen at one-month follow-up.
- The authors describe the combined approach as novel and possibly synergistic for select palliative patients, but they state larger studies are needed for patient selection, duration of benefit, and safety.
- Systematic review and meta-analysis of 8 randomized controlled trials including 543 adults, comparing short-term peripheral nerve stimulation with sham or usual care.
- The primary outcome was change in average pain intensity during the implantation period.
- Average pain fell during implantation at 1-4 weeks (SMD -0.48, 95% CI -0.71 to -0.26) and 5-8 weeks (SMD -0.96, 95% CI -1.22 to -0.70), but not after electrode removal.
- The authors describe the evidence as preliminary: pain relief occurs during implantation, but not all outcomes show benefit that persists after removal.
AI summary not available. Read the source abstract on PubMed.
- Multicentre, randomised, double-blind trial in 873 analysed adults (914 randomised) undergoing video-assisted thoracoscopic lung resection.
- Perioperative low-dose esketamine (bolus at induction, then intra- and postoperative infusion for 48 h) was compared with normal saline.
- Chronic pain at 3 months was 14.7% with esketamine versus 21.2% with control (adjusted OR 0.62, 95% CI 0.43-0.90; P=0.013).
- A post hoc definition using NRS ≥3 during coughing also favoured esketamine (adjusted OR 0.39, 95% CI 0.19-0.84; P=0.015), and the authors report no increase in adverse effects.
- Prospective longitudinal cohort of 226 adolescents aged 11-17 with acute musculoskeletal injury, followed at under 30 days, 3 months and 12 months, analyzed with mixed effects models.
- Biobehavioral factors (sleep, anxiety and depressive symptoms, pain-related cognitions and behaviors) and psychophysical measures (conditioned pain modulation, temporal summation) were examined as predictors of pain intensity, disability and quality of life.
- Sleep duration was linked to pain intensity within persons, and pain-related cognitions and behaviors were linked to pain intensity, disability and quality of life; temporal summation was the only psychophysical factor associated with pain outcomes, with higher average temporal summation tied to higher pain intensity.
- The authors conclude biobehavioral factors matter more than psychophysical ones for longer-term recovery and suggest targeting anxiety, depression, pain-specific cognitions and sleep.
- Two large presurgical cohorts, one undergoing total knee arthroplasty and one undergoing thoracic surgery, were analyzed to test the Risk of Pain Spread framework in surgical patients.
- The analysis combined latent-variable, regression, Bayesian network, and mediation methods to relate psychosocial and sociodemographic factors to surgical-site, nonsurgical-site, and widespread pain.
- Fatigue was the most consistent correlate of pain outcomes across cohorts and methods, independent of other measured risk factors, and it accounted for much of the shared variance with pain intensity.
- Nonsurgical-site pain linked pain intensity to widespread pain, and the authors conclude the findings externally validate the ROPS framework in surgical populations.
- Retrospective cohort of 10 patients, drawn from 57 who underwent BVNA, all of whom had post-procedure MRI obtained for treatment failure or new symptoms.
- Exposure was 7-minute basivertebral nerve ablation, with lesion height and width measured on sagittal MRI by two independent reviewers.
- Mean lesion height was 11.6 mm (SD 1.2) and mean width was 10.9 mm (SD 1.4), with reviewer reproducibility described as acceptable.
- The authors conclude that 7-minute lesions averaged about 1.1 cm, within the range reported for historical 15-minute ablations.
- This single case report describes one 79-year-old woman with chronic low back pain and left anterior hip and groin pain.
- Lumbar discography at L4-5 reproduced her hip pain through anterior contrast extravasation into the iliopsoas, and intradiscal steroid was then given and repeated.
- After steroid, pain fell by approximately 50% overall, and imaging over about 3 years showed less anterior spread and eventual resolution of the grade V tear.
- The authors conclude that the case shows atypical discogenic referral mimicking hip pathology, with annular stabilization on serial imaging after steroid therapy.
- In 93 healthy volunteers across three experiments, heat was applied to eight forearm sites in two quantitative sensory testing tasks.
- Thermode type (ATS, CHEPS, T03) and stimulation duration (3 s vs 8 s) were varied to compare pain threshold, tolerance, and temperature-pain correlation.
- Briefer 3 s stimuli gave higher pain tolerance (t(45)=5.84, p<0.001), and larger-surface thermodes gave lower tolerance (t(45)=4.79, p<0.001); the duration effect on threshold was weak (p=0.03).
- The authors conclude that tolerance is sensitive to stimulus features, while thresholds and temperature-pain correlations were stable, so methods need standardizing.
- Preclinical mouse study comparing male and female mice with astrocyte-specific Orai1 deletion after peripheral nerve injury, examining spinal cord pain signaling.
- Conditional deletion of astrocytic Orai1 was compared with intact controls, measuring mechanical allodynia, cytokines, synaptic transmission, and metabolites.
- Orai1 deletion attenuated mechanical allodynia in males but not females, despite comparable suppression of store-operated Ca2+ entry in both sexes, and reduced TNFα, IL-6, and IL-33 production.
- Orai1 loss also prevented injury-induced potentiation of excitatory synaptic transmission and shifted astrocyte metabolism, which the authors link to a sex-dimorphic mechanism and a possible male-predominant therapeutic target.
- This preclinical mouse study examined early-life stress (ELS) effects on neonatal pain, with the abstract reporting no sample sizes or statistics.
- Conditional deletion of mineralocorticoid receptors (MR), but not glucocorticoid receptors, from immature sensory neurons prevented ELS-evoked neonatal pain, while systemic eplerenone did not acutely alter pain.
- Blocking peripheral somatostatin (Sst) receptors increased spontaneous nocifensive behaviors in control pups but not in ELS pups, and peripheral octreotide reversed cold and pressure hypersensitivity after ELS.
- The authors conclude that MR signaling in sensory neurons reduces Sst expression and that disrupted peripheral Sst antinociception contributes to neonatal pain after ELS.
AI summary not available. Read the source abstract on PubMed.
- Randomized, double-blind, placebo-controlled crossover trial in 30 patients with chronic post-surgical peripheral neuropathic pain at a French university hospital.
- Participants took oral therapeutic-dose acetaminophen (3 g/day) or placebo for 7 days each, separated by a 7-day washout.
- Mean pain intensity did not differ from placebo (effect size -0.09, 95% CI -0.45 to 0.26, P = 0.607), and no secondary outcomes differed.
- The authors found no clinically meaningful short-term add-on analgesic benefit and no adverse events, and advised informing patients about the risks of long-term use.
- Secondary analysis of whole-blood RNA sequencing from seven human cohorts, nearly 500 samples, across acute, postoperative, chronic localised and chronic widespread pain.
- Gene-level meta-analyses, pathway enrichment and immune cell-specific gene ontologies were used to relate inflammatory activity to current pain, future trajectories and within-person change.
- Inflammation was among the strongest correlates of pain, but its direction depended on pain state: positive with pain intensity in acute and postoperative pain, inverted in chronic localised pain.
- Authors conclude inflammation plays context-dependent roles, possibly supporting resolution after acute injury but becoming dysregulated in chronic and nociplastic pain, which may help explain conflicting literature.
- Secondary analysis of a multicenter randomized trial (FIT Teens) including 317 adolescents with juvenile fibromyalgia.
- Participants received CBT, graded aerobic exercise, or CBT plus neuromuscular exercise, and changes in fear of movement and pain catastrophizing through 3 months were tracked.
- Reductions in both fear of movement and pain catastrophizing predicted functional disability at 3 months (p's<.05), but only reduced fear of movement predicted disability at 12 months.
- The authors suggest prioritizing strategies that reduce fear of movement in non-drug interventions for this population.
- Preclinical study in male and female ICR mice, using chambers that measured crossing and horizontal movement across three visceral pain models.
- Intracolonic TNBS (colon) and intraperitoneal cyclophosphamide (bladder) were compared with intraperitoneal lactic acid, a more established visceral pain model.
- All three models reduced crossing and movement and increased hunched posture and facial grimace, though cyclophosphamide effects were weaker; ketoprofen and morphine were less effective against TNBS and cyclophosphamide.
- The authors propose this locomotor-depression procedure could help identify better visceral pain pharmacotherapies.
- Using the Burn Model System database, this study applied growth mixture modeling to 1354 adult burn survivors followed to 5 years, with 909 geocoded.
- Neighborhood disadvantage (Area Deprivation Index, per 1-SD increase) was compared with pain trajectory membership, first adjusting for demographic, clinical and site factors, then for individual socioeconomic factors.
- Three trajectories emerged (Low 56%, Moderate 30%, High 14%); neighborhood disadvantage tracked Moderate Pain (RRR 1.27, 95% CI 1.03-1.55) but not High Pain.
- Estimates weakened after individual socioeconomic adjustment, while pre-injury unemployment and public insurance were associated with higher High Pain risk after correction for multiple comparisons.
- Pilot randomized, triple-blind trial of 36 patients undergoing bilateral total knee arthroplasty, split evenly across placebo, 400 mg, and 800 mg oral CBD groups.
- Four perioperative doses of oral CBD were compared with placebo, all given alongside standardized anesthesia and multimodal analgesia.
- Dunnett's testing found no significant difference in 72-hour opioid use versus placebo (400 mg: 144 vs 209 MME, p=0.10; 800 mg: 203.2 vs 209 MME, p=0.98).
- Post hoc testing showed lower opioid use with 400 mg (p=0.04), and the authors frame the findings as a potential signal that needs larger trials.
- Cross-sectional analysis comparing 2026 state Medicaid fee schedules for four PNS CPT codes with Medicare rates, plus Medicare utilization and payment trends from 2013 to 2024.
- Medicaid professional fees were compared with Medicare rates before and after Medicare Wage Index adjustment, using Medicaid-to-Medicare indices and wRVU-normalized differentials.
- Median wage-adjusted Medicaid reimbursement was below Medicare for all codes, reported as 14.0% (64575, facility) to 36.7% (64553, non-facility). Parity was missed in 61.7% to 86.5% of states.
- Medicare utilization diverged by procedure: it rose for 64555 and 64590 but fell for 64575 and 64553, even as average standardized payment rose for all four codes.
- Baseline data from an ongoing randomized trial of older adults with chronic musculoskeletal pain and subjective cognitive concerns, analyzed in 251 participants with complete data.
- An exploratory hierarchical cluster analysis grouped participants on four pain and cognitive measures, and logistic regression linked cluster membership to demographic and psychosocial variables.
- Three profiles emerged: lowest symptom burden (n=101), mixed burden (n=93), and highest burden (n=57), with several demographic, mental health, and psychosocial factors distinguishing them.
- The authors present these profiles as a first step toward identifying which older adults may benefit most from interventions for co-occurring pain and cognitive concerns.
AI summary not available. Read the source abstract on PubMed.
- Preclinical study combining rat behavioral and knockout models with analyses of human postsurgical skin samples, including a meta-analysis of human skin data.
- Intraplantar 7α,25-dihydroxycholesterol, a GPR183 ligand, produced lasting nociception that was prevented by the selective GPR183 antagonist SAE-14; NOS isoforms contributed to this response.
- GPR183 expression rose in injured rat paw tissue and human postsurgical skin, and SAE-14 reversed incisional hypersensitivity; the abstract reports no effect sizes or p values.
- Ablating Langerhans cells and removing mature B and T cells did not abolish the hypersensitivity, so the authors suggest GPR183+ macrophages are the most likely drivers and propose GPR183 antagonism for pain.
- Prospective single-arm observational cohort of 274 patients with chronic coccygodynia and coccygeal instability, drawn from 668 treated, at a specialized spine setting.
- Patients received prone, unguided three-position coccygeal infiltration with mepivacaine 1% and triamcinolone 40 mg, with no comparison group.
- Mean NRS fell from 5.55 at baseline to 1.99 by day 27 (change -3.56, 95% CI -3.90 to -3.22; P<0.001), and 80.3% reached ≥30% improvement.
- Pain declined further in diary week 4 (3.51 to 2.73; change -0.78, 95% CI -0.95 to -0.61), though the authors state causal efficacy cannot be established.